About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Effect of Pitavastatin on Bone

Effect of Pitavastatin on Bone

NCT06359353·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Seoul National University Bundang Hospital

With

JW Pharmaceutical

Age

0–75

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Patients who are under the age of 75 and are postmenopausal.
Individuals diagnosed with osteopenia or osteoporosis, exhibiting a T-score ranging from -3.0 to -1.5.
Patients with hypercholesterolemia starting pitavastatin for the first time.
Patients exhibiting baseline bone resorption markers, specifically C-telopeptide levels of 0.300 ng/mL or above, or NTX levels above 16.5 nmolBCE/L.

You may not be if

Patients who have used a statin medication for more than one month within the last 3 months.
Patients who have used oral or injectable glucocorticoids for more than one week within the last 3 months.
Patients currently using thiazolidinediones, a class of oral antidiabetic medications.
Patients undergoing treatment for malignant tumors.

The record

StatusCompleted

PhasePhase 4

Taking part70

StartedApr 2019

UpdatedApr 11, 2024

Conditions

Osteoporosis, Osteopenia Hypercholesterolemia Menopausal Osteoporosis

Where1

Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea